Parexel has formed alliances with three healthcare institutions: PKUCare Luzhong Hospital, West China Medical Center, and Shanghai Xuhui Central Hospital, to provide enhanced support for customers conducting Phase I studies in China.   “Parexel has seen a consistent increase in the number of Phase I studies both in healthy subjects and patients being conducted in China in recent years,” said Gadi Saarony, Executive Vice President and Chief Clinical Research Services Officer. “While there is gr...